Sterivet Laboratories Ltd said it is proceeding with development of a new drug to treat navicular disease in horses. The company said it received an unspecified financial contribution from the National Research Council of Canada to help develop the drug for treating navicular disease, which affects horses' feet. Sterivet said the drug has produced promising results in limited clinical trials conducted over the past 18 months in Ontario. 